This comprehensive case study explores Kymanox’s approach to FDA inspection readiness through deviation backlog resolution and cleaning validation remediation. Our team of Subject Matter Experts (SMEs) collaborated closely with biopharmaceutical contract manufacturing stakeholders to implement measurable improvements across deviation investigations, laboratory investigations, cleaning validation execution, and compliance gap remediation for critical Pre-Approval Inspection (PAI) preparation.
CHALLENGE
SOLUTION
RESULTS
- Biopharmaceutical contract services organization required urgent FDA pre-approval inspection preparation facing two critical compliance challenges threatening approval timeline.
- Large backlog of manufacturing deviations and laboratory investigations tied to Process Performance Qualification (PPQ) and commercial launch inventory campaign required rapid resolution.
- Multiple validation gaps in cleaning methods necessitated complete re-execution of cleaning validation studies ensuring regulatory compliance and product quality.
- Urgent resolution of compliance gaps essential passing PAIs and enabling product commercialization without delays or regulatory observations.
- Deployed skilled Kymanox investigation resources efficiently managing and dramatically reducing backlog of manufacturing deviations and laboratory investigations meeting FDA inspection timeline.
- Provided specialized technical expertise executing complex deviation investigations enabling client personnel to concentrate on other critical inspection preparation aspects.
- Delivered comprehensive microbial, analytical, and environmental monitoring support resolving cleaning validation issues and compliance gaps.
- Addressed cleaning validation protocol deviations identifying root causes and implementing corrective actions ensuring protocol compliance.
- Established scientifically sound, regulatory-appropriate acceptance criteria for cleaning validation studies based on product characteristics and toxicological assessments.
- Recommended improved cleaning methods and validation approaches enhancing cleaning effectiveness, reducing residues, and ensuring product quality protection.
- Successfully increased client’s throughput for processing deviation and investigation backlog by 3x-5x compared to internal capability dramatically accelerating inspection readiness.
- Enhanced overall operational efficiency by supplementing client’s expertise with specialized investigation and validation skills accelerating critical project goals.
- Successfully alleviated client’s compliance workload enabling focused, strategic preparation for PAI without resource constraints.
- Resolved cleaning validation gaps through comprehensive re-execution studies establishing robust, compliant validation protocols supporting regulatory approval.
- Enabled client to meet FDA inspection timeline with confidence demonstrating compliance readiness and quality system effectiveness.